Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

The blood-brain barrier in health and disease: Important unanswered questions.

Profaci CP, Munji RN, Pulido RS, Daneman R.

J Exp Med. 2020 Apr 6;217(4). pii: e20190062. doi: 10.1084/jem.20190062.

PMID:
32211826
2.

3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice.

Fu H, Hussaini SA, Wegmann S, Profaci C, Daniels JD, Herman M, Emrani S, Figueroa HY, Hyman BT, Davies P, Duff KE.

PLoS One. 2016 Jul 28;11(7):e0159463. doi: 10.1371/journal.pone.0159463. eCollection 2016.

3.

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease.

Khan UA, Liu L, Provenzano FA, Berman DE, Profaci CP, Sloan R, Mayeux R, Duff KE, Small SA.

Nat Neurosci. 2014 Feb;17(2):304-11. doi: 10.1038/nn.3606. Epub 2013 Dec 22.

4.

The effects of healthy aging on the mnemonic benefit of survival processing.

Stillman CM, Coane JH, Profaci CP, Howard JH Jr, Howard DV.

Mem Cognit. 2014 Feb;42(2):175-85. doi: 10.3758/s13421-013-0353-2.

5.

NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.

Olszewski RT, Janczura KJ, Ball SR, Madore JC, Lavin KM, Lee JC, Lee MJ, Der EK, Hark TJ, Farago PR, Profaci CP, Bzdega T, Neale JH.

Transl Psychiatry. 2012 Jul 31;2:e145. doi: 10.1038/tp.2012.68.

6.

Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Neale JH, Olszewski RT, Zuo D, Janczura KJ, Profaci CP, Lavin KM, Madore JC, Bzdega T.

J Neurochem. 2011 Aug;118(4):490-8. doi: 10.1111/j.1471-4159.2011.07338.x. Epub 2011 Jul 1. Review.

7.

Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.

Profaci CP, Krolikowski KA, Olszewski RT, Neale JH.

Psychopharmacology (Berl). 2011 Jul;216(2):235-43. doi: 10.1007/s00213-011-2200-0. Epub 2011 Feb 16.

Supplemental Content

Loading ...
Support Center